Breadcrumb

Breadcrumbs

Estás en:

Asset Publisher

INFORME INHATA

InformeGene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment

Objetivo: This health technology assessment evaluates the effectiveness, safety, and cost-effectiveness of gene expression profiling (GEP) tests for people with early-stage invasive breast cancer. It also evaluates the budget impact of publicly funding GEP tests and the experiences, preferences, and values of people with early-stage invasive breast cancer.

Autoría: Ontario Health

Idioma: inglés

Fuente: INAHTA

Año de publicación: 2020